Medical Device and Pharmaceutical Product Development and Compliance

Cognition Blog

Our blog navigates product development and compliance for the life science industry. Our solutions save time and money, delivering products with less risk.

Blog Feature

cockpit | Cognition News

Cockpit 10 Release: Feature Roundup | Cognition Corporation

By: Cognition Corporation
February 15th, 2021

Giving customers more time to focus on developing great products. If you are part of a product development team, you know how tedious and time-consuming documentation can be to manage in various word or excel files. We set out to solve that problem over 10 years ago when we launched our solution, Cockpit. Our goal was to provide a unified and scalable environment to enable companies to structure data and automate processes for more efficient and accurate product development.

Read More

Share

Blog Feature

Cognition News | NAVIGATE

A Brief Recap of NAVIGATE2019

By: Cognition Corporation
September 10th, 2019

NAVIGATE2019, Cognition’s annual user conference, has officially wrapped up. We heard many great talks, panels, and discussions over the course of the two-day event. Here’s a brief overview of the conference—what we discussed, what we learned, and how that information will impact Cognition moving forward.

Read More

Share

How to Approach Usability Engineering & Use Error Analysis

Learn how activities like Use Error Analysis can lead to more dynamic, impactful risk management.

Subscribe to the blog and get this guide for free

Blog Feature

Cognition News | Drug Stability

Drug Stability Reporting for Pharmaceutical Companies

By: Cognition Corporation
August 29th, 2019

Drug stability reporting has been a major area of interest for Cognition as of late. To get a better understanding the current environment, we coordinated our Summer Internship Program around this topic. Led by our interns Olivia O'Brien and Brigitte Cronin, this effort has yielded a vast amount of important and intriguing insights about the current state of drug stability reporting in pharmaceutical industries. Here are a few of those insights and what they can tell us about this vital aspect of pharmaceutical compliance.

Read More

Share